STROVESA Trademark

Trademark Overview

On Thursday, April 2, 2020, a trademark application was filed for STROVESA with the United States Patent and Trademark Office. The USPTO has given the STROVESA trademark a serial number of 88857069. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 18, 2023. This trademark is owned by Teva Pharmaceutical Industries Ltd.. The STROVESA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular diseases
strovesa

General Information

Serial Number88857069
Word MarkSTROVESA
Filing DateThursday, April 2, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 18, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 22, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 9, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTeva Pharmaceutical Industries Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressTel Aviv 6944020
IL
Party NameTeva Pharmaceutical Industries Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressPetach Tikva 49131
IL

Trademark Events

Event DateEvent Description
Monday, September 18, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 18, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, February 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 14, 2023SOU EXTENSION 4 GRANTED
Tuesday, February 14, 2023SOU EXTENSION 4 FILED
Tuesday, February 14, 2023SOU TEAS EXTENSION RECEIVED
Friday, August 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 10, 2022SOU EXTENSION 3 GRANTED
Wednesday, August 10, 2022SOU EXTENSION 3 FILED
Wednesday, August 10, 2022SOU TEAS EXTENSION RECEIVED
Friday, February 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 16, 2022SOU EXTENSION 2 GRANTED
Wednesday, February 16, 2022SOU EXTENSION 2 FILED
Wednesday, February 16, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, August 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 16, 2021SOU EXTENSION 1 GRANTED
Monday, August 16, 2021SOU EXTENSION 1 FILED
Monday, August 16, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, February 16, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 22, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 22, 2020PUBLISHED FOR OPPOSITION
Wednesday, December 2, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, November 15, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 12, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 12, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 4, 2020ASSIGNED TO LIE
Thursday, September 10, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 10, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 10, 2020NON-FINAL ACTION E-MAILED
Wednesday, June 10, 2020NON-FINAL ACTION WRITTEN
Tuesday, June 2, 2020ASSIGNED TO EXAMINER
Thursday, April 9, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 6, 2020NEW APPLICATION ENTERED

Related Keywords

strovesa diseases cardiovascular treatment preparations pharmaceutical